High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow

Jonathan Ozik(Argonne National Laboratory), Nicholson Collier(Argonne National Laboratory), Justin M. Wozniak(Argonne National Laboratory), Charles M. Macal(Argonne National Laboratory), Chase Cockrell(University of Chicago), Samuel H. Friedman(Opto-Knowledge Systems (United States)), Ahmadreza Ghaffarizadeh(University of Southern California), Randy Heiland(Indiana University Bloomington), Gary An(University of Chicago), Paul Macklin(Indiana University Bloomington)
BMC Bioinformatics
December 1, 2018
Cited by 67Open Access
Full Text

Abstract

BACKGROUND: Cancer is a complex, multiscale dynamical system, with interactions between tumor cells and non-cancerous host systems. Therapies act on this combined cancer-host system, sometimes with unexpected results. Systematic investigation of mechanistic computational models can augment traditional laboratory and clinical studies, helping identify the factors driving a treatment's success or failure. However, given the uncertainties regarding the underlying biology, these multiscale computational models can take many potential forms, in addition to encompassing high-dimensional parameter spaces. Therefore, the exploration of these models is computationally challenging. We propose that integrating two existing technologies-one to aid the construction of multiscale agent-based models, the other developed to enhance model exploration and optimization-can provide a computational means for high-throughput hypothesis testing, and eventually, optimization. RESULTS: In this paper, we introduce a high throughput computing (HTC) framework that integrates a mechanistic 3-D multicellular simulator (PhysiCell) with an extreme-scale model exploration platform (EMEWS) to investigate high-dimensional parameter spaces. We show early results in applying PhysiCell-EMEWS to 3-D cancer immunotherapy and show insights on therapeutic failure. We describe a generalized PhysiCell-EMEWS workflow for high-throughput cancer hypothesis testing, where hundreds or thousands of mechanistic simulations are compared against data-driven error metrics to perform hypothesis optimization. CONCLUSIONS: While key notational and computational challenges remain, mechanistic agent-based models and high-throughput model exploration environments can be combined to systematically and rapidly explore key problems in cancer. These high-throughput computational experiments can improve our understanding of the underlying biology, drive future experiments, and ultimately inform clinical practice.


Related Papers

No related papers found

Powered by citation graph analysis